Blue Owl sold half of its SpaceX holding at $1.25 trillion valuation, reports CEO
Blue Owl shares surged after the private credit firm reported 10x gains from its SpaceX investment
Blue Owl sold about half its investment in SpaceX at a $1.25 trillion valuation, the alternative asset manager's co-CEO Marc Lipschultz said on Thursday.
"Specifically at SpaceX... we made about 10 times our money on that investment," Lipschultz said on a conference call with analysts. "We've sold about half of it at a $1.25 trillion valuation, still holding about half of it."
The major American alternative asset management firm specializing in private credit, GP strategic capital, and real estate focuses on providing financing to middle-market companies and, as of early 2026, is navigating high investor redemption requests from its funds
Operates through three primary strategies: credit or direct lending, GP strategic capital or minority stakes in other asset managers, and real estate or net lease solutions.
SpaceX is expected to go public later this year at a possible valuation of $1.75 trillion, raising about $75 billion in what would be the largest public listing on record. The deal could put founder and CEO Elon Musk on track to become the world's first trillionaire.
New York-based Blue Owl was one of SpaceX's earliest lenders and eventually made an equity investment, Lipschultz added.
Notably, Blue Owl bought stock in two classes of shares in SpaceX in 2021, a 2025 securities filing shows.
-
SpaceX shares drop 49 percent from peak ahead of first earnings report
-
Anthropic weighs mandatory employee stock sales after IPO: reports
-
Alphabet shares fall as AI spending forecast climbs to $205bn
-
Southern Water ex-CEO charged over alleged wastewater testing fraud
-
EU clears Paramount’s $110 billion Warner Bros. takeover with conditions
-
Amazon lays off employees in artificial general intelligence division
-
Brent Crude oil hovers near $95 as Rubio vows U.S. will ‘continue to protect shipping’ in Hormuz
-
TikTok chief security officer to testify before US House amid regulatory scrutiny
